Ameritas Investment Partners’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$200K Buy
38,178
+4,445
+13% +$15.1K 0.01% 1396
2026
Q1
$59.4K Hold
33,733
– – ﹤0.01% 1998
2025
Q4
$79.3K Hold
33,733
– – ﹤0.01% 1840
2025
Q3
$103K Sell
33,733
-7,491
-18% -$21.4K ﹤0.01% 1675
2025
Q2
$115K Buy
+41,224
New +$136K ﹤0.01% 1662
2023
Q2
– Sell
-28,616
Closed -$24.2K – 3132
2023
Q1
$24.2K Hold
28,616
– – ﹤0.01% 2391
2022
Q4
$36.6K Hold
28,616
– – ﹤0.01% 2256
2022
Q3
$48K Hold
28,616
– – ﹤0.01% 1998
2022
Q2
$61K Buy
+28,616
New +$76.1K ﹤0.01% 1855

Other funds holding CLOV

Ameritas Investment Partners's CLOV Position: Q2 2026 in Review

Ameritas Investment Partners increased its Clover Health Investments (CLOV) stake by 13% in Q2 2026, buying an estimated $15.1K and bringing the position to 38,178 shares worth $200K. The position accounts for 0.01% of the portfolio, ranked #1396.

Ameritas Investment Partners first reported a position in CLOV in Q2 2022 and has held it in 9 quarters since. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Ameritas Investment Partners held 38,178 shares of Clover Health Investments worth $200K as of Q2 2026.
  • Ameritas Investment Partners bought 4,445 Clover Health Investments shares in Q2 2026, an estimated $15.1K.
  • Clover Health Investments made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1396 holding.
  • Ameritas Investment Partners first reported a position in Clover Health Investments in Q2 2022 and has held it in 9 quarters since.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.